Skip to main content

New Products

  • Red Carpet Manicure makes foray into nail lacquer category

    HAUPPAUGE, N.Y.  — Red Carpet Manicure has announced that it is expanding beyond the at-home LED gel polish category to enter the nail lacquer segment.
 

  • Ginger Ale a favorite among flavored CSDs

    PLANO, Texas — Canada Dry Ginger Ale has long been a staple in the flavored soft drink category. The brand, invented by a pharmacist in 1904, has seen an uptick in sales that Dr Pepper Snapple Group attributes to “the perceived healthfulness of ginger ale as a CSD flavor.” Sales were up 20% in the drug store channel last year, according to Nielsen.

  • Sun Pharma approved for generic Temodar

    MUMBAI — Sun Pharmaceutical Industries announced that the Food and Drug Administration has granted final approval for its generic version of Temodar temozolomide capsules in 5-mg, 20-mg, 100-mg 140-mg, 180-mg and 250-mg form.

  • Mucinex to tap into robust nighttime market

    PARSIPPANY, N.J. — Reckitt Benckiser this season extended its line of popular Mucinex Fast-Max to include a product for nighttime cold and flu relief in both liquid and tablet form.

    According to the company, nighttime relief is a $600 million market in the United States, and Mucinex Fast-Max is differentiated from its competitors because it contains an active ingredient for nasal decongestion.

  • Report: Florida lawmakers eye telemedicine

    NEW YORK — Lawmakers in Florida are looking into ways to ease regulatory limitations for telemedicine in an effort to increase access to care and create “a fertile ground” for the technology to be used, according to a local report.

  • New device aims to keep Rx drugs out of the 'wrong hands'

    NOVATO, Calif. — 4ThoughtProducts has announced the release of Pill Pod, a new safety device that serves as a "keyless" drug lock box for use in the home.

  • Alberto V05 introduces new Men's 3-in-1

    STAMFORD, Conn. — The Alberto VO5 brand, which is owned by High Ridge Brands, has introduced its new VO5 Men's 3-in-1, combining VO5 shampoo, conditioner and body wash.  

  • Janssen Biotech: Second indication won for cancer drug Imbruvica

    HORSHAM, Pa. — Janssen Biotech on Wednesday announced the Food and Drug Administration has approved Imbruvica (ibrutinib) capsules for the treatment of patients with chronic lymphocytic leukemia who have received at least one prior therapy. Imbruvica was first approved in November 2013 for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. Both indications are based on an overall response rate. An improvement in survival or disease-related symptoms has not been established.

X
This ad will auto-close in 10 seconds